Hints and tips:
...“That growth in holdings is going to happen a lot,” says Hector McNeil, co-chief executive of HANetf....
...“Medical cannabis is an emerging industry with huge growth potential and significant investor interest,” said Hector McNeil, co-founder and co-chief executive at HANetf....
...health body asking boards to ensure that they had implemented all alerts issued by NHS Digital between March and May 2017 “and taken essential action taken to secure local firewalls”, added the NAO Keith McNeil...
...J&J last week agreed the sale of its ortho-clinical diagnostics unit, which includes blood testing equipment, to Carlyle, the private equity group, for $4.15bn as part of efforts to narrow the group’s focus...
...In 2011 the US Food and Drug Administration said it had imposed a “consent decree” on J&J’s McNeil-PPC subsidiary and two of its offices to force the company to improve manufacturing standards....
...one of several US legal actions related to marketing of its products, the report describes a “doctor for a day” programme used until 2003 that was developed by the sales force and “not …management” of Ortho-McNeil...
...In its decision the US Court of Appeals for the Federal Circuit in Washington found the original patent held by Centocor Ortho Biotech, a unit of J&J, and New York University, was invalid....
...The Food and Drug Administration said it had imposed a “consent decree” on J&J’s McNeil-PPC subsidiary and two of its offices to force the company to improve its manufacturing standards....
...But Mr McNeil cautioned the figures pre-dated the growing impact of austerity measures for governments, which provide two-thirds of all support for R&D into neglected diseases....
...Pfizer’s decision to close its research laboratory at Sandwich is widely seen as a setback for recovery in Britain, a country that played a leading role in the development of the modern research-based pharmaceutical...
...J&J said: “McNeil kept the FDA informed of its actions and removed the product from the market in a compliant manner....
...Bill Weldon, the head of J&J, told the hearings that McNeil, its consumer products subsidiary that makes Motrin, “should have handled things differently” and that his group had “let the public down”....
...In Metastatic Prostate Cancer Study”, in whichit stated that it was “pleased to note” an announcement by Ortho Biotech, a unit of Cougar Biotechnology....
...It comes at a time of growing FDA enforcement efforts triggered by production problems in the US by pharmaceutical companies, including Baxter and Genzyme, as well as J&J....
...J&J has been drawn directly into the spat in spite of its policy of arm’s length management of subsidiaries such as McNeil Consumer Healthcare, the producer of the affected products....
...The terms of the agreement between J&J’s subsidiary Centocor Ortho Biotech and Schering-Plough allow arbitration within 30 days of a change of ownership....
...Isis Pharmaceuticals rose 4.2 per cent to $13.30 after it announced a collaboration with Ortho-McNeil, a unit of Johnson & Johnson , up 1 per cent at $63.11, for the treatment of various medical disorders...
...It is being financed by Ortho-Clinical Diagnostics, a J&J company, and the Johnson & Johnson Corporate Office of Science and Technology in conjunction with SEHTA, Finance South East and the South East England...
...The retailer said it would start selling a monthly supply of generic versions of Ortho Cyclen and Ortho Tri Cyclen birth control drugs for $9, compared to current prices of $24 to $30, introducing a second...
...The Johnson & Johnson arm McNeil retained responsibility for the retail and foodservice business (including tabletop products), with Tate & Lyle supplying McNeil....
...Worries about the safety of Cox-2 painkillers such as Vioxx and Celebrex last week led to an FDA advisory panel recommending that pharmaceuticals companies be banned from advertising some pain medicines...
...Thus Texas Instruments got out of home computers and defence electronics to focus on semiconductors; Westinghouse evolved into CBS, the media group; Imperial Chemical Industries spun out its pharmaceuticals...
...A more recent form of medication, branded Concerta, has been developed by McNeil Consumer and Speciality Pharmaceuticals....
International Edition